veriNOS pharmaceuticals
PrivateLast Round
VC Round
Jul 11, 2019
Total Funding Raised
$6.6M
Company Overview
veriNOS pharmaceuticals operates in Healthcare & Life Sciences and is based in Würzburg. Its latest recorded funding round was a VC Round in July 2019.
veriNOS pharmaceuticals is a biotechnology company that develops small-molecule therapeutics for the treatment of cerebrovascular diseases, including traumatic brain injury and retinal edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
veriNOS pharmaceuticals Comparables
Compare veriNOS pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurophyxia B.V. | 85% | |
| Bryan Therapeutics, Inc. | 76% | |
| KNOW Bio | 62% |
For institutional investors. Book with your work email.
veriNOS pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 11, 2019 | ||||
| VC Round | Jan 21, 2016 | ||||
| Series F | Jul 1, 2013 | ||||
| VC Round | Feb 1, 2006 |
For institutional investors. Book with your work email.
veriNOS pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3i Group | VC Round |
| Hanseatic Asset Management LBG | VC Round, Series F |
| Creathor Venture | VC Round |
| Future Capital AG | VC Round |
| EMBL Ventures | VC Round |
| Bayern Kapital | VC Round, Series F |
| KfW Development Bank | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 11, 2019
$11M round led by HeidelbergCapital Private Equity.
- Jan 21, 2016
$22M raised from Fort Rock Capital and others.
For institutional investors. Book with your work email.
veriNOS pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about veriNOS pharmaceuticals's valuation, stock price, and market status.
Is veriNOS pharmaceuticals a public or private company?
veriNOS pharmaceuticals is a private company.
What is the current stock price of veriNOS pharmaceuticals?
veriNOS pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks veriNOS pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is veriNOS pharmaceuticals worth (valuation)?
Valuation information for veriNOS pharmaceuticals is not publicly available.
Can I buy veriNOS pharmaceuticals stock?
veriNOS pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was veriNOS pharmaceuticals's last funding round?
veriNOS pharmaceuticals's most recent funding round was VC Round on July 11, 2019.
Who are the main investors in veriNOS pharmaceuticals?
Key investors in veriNOS pharmaceuticals include EMBL Ventures, HeidelbergCapital Private Equity.
Will veriNOS pharmaceuticals IPO soon?
No public IPO plans have been announced for veriNOS pharmaceuticals.
How can I track veriNOS pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in veriNOS pharmaceuticals's shares on secondary markets.